Nov. 17, 2025 — Royal Philips has introduced DeviceGuide, an AI-powered device tracking* solution that assists ...
Nov. 17, 2025 — GE HealthCare has announced that Cardiovascular Associates of America (CVAUSA) plans to broaden its ...
Nov. 12, 2025 — The Association of Black Cardiologists (ABC) has released new findings from a national survey exposing a ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens ...
Nov. 12. 2025 — The American Heart Association’s Council on Clinical Cardiology has selected Roxana Mehran, MD, as the ...
Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...
Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...
Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Nov. 12, 2025 — AISAP, a provider of AI Point-of-Care Diagnostics, has announced a field initiative in Ghana, deploying ...
Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
Nov. 10, 2025 — Kestra Medical Technologies, a wearable medical device and digital healthcare company, has announced ...
Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...
Nov. 8, 2025 — Sanjay Rajagopalan, MD, MBA, Chief of Cardiovascular Medicine at University Hospitals Harrington Heart & ...
November 17, 2025
